The development of androgen-independent prostate cancer

Nature Reviews. Cancer
B J Feldman, D Feldman

Abstract

The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.

References

Nov 1, 1991·Molecular Endocrinology·W L McGuireS A Fuqua
Feb 1, 1986·Endocrine Reviews·F LabrieG Monfette
May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
Dec 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·H SuzukiJ Shimazaki
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·A Y LiuR L Vessella
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·S Yeh, C Chang
Aug 16, 1996·The Journal of Biological Chemistry·L V Nazareth, N L Weigel
Jan 1, 1996·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·P KoivistoO P Kallioniemi
Feb 21, 1998·Nucleic Acids Research·B GottliebM Trifiro
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·R M LavinskyD W Rose
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MiyamotoC Chang
Oct 8, 1998·The New England Journal of Medicine·M A EisenbergerB A Lowe
Nov 26, 1998·The New England Journal of Medicine·C K Osborne
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·X WuC L Sawyers
Feb 27, 1999·Endocrine Reviews·E RuijterJ Schalken
May 4, 1999·Trends in Cell Biology·T Maehama, J E Dixon
Jun 11, 1999·The Urologic Clinics of North America·J T Isaacs
Jun 16, 1999·Endocrine Reviews·N J McKennaB W O'Malley
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·A O BrinkmannJ Trapman
Aug 24, 1999·Cancer Metastasis Reviews·M J PilatK J Pienta
Aug 24, 1999·Cancer Metastasis Reviews·M Bui, R E Reiter
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Mar 14, 2000·The Journal of Biological Chemistry·B P ZhouM C Hung
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo

❮ Previous
Next ❯

Citations

Nov 25, 2011·Der Urologe. Ausg. A·C-H OhlmannM Stöckle
Mar 17, 2005·World Journal of Urology·Alan SoColleen Nelson
Nov 22, 2011·World Journal of Urology·Carsten-H OhlmannPatrick J Bastian
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·K O'ConnorR W G Watson
Apr 17, 2009·Cancer Causes & Control : CCC·Janet K Hess-Wilson
Aug 5, 2010·Pharmaceutical Research·Alexis L TwiddyKishor M Wasan
Apr 19, 2006·Current Oncology Reports·Kathleen W Beekman, Maha Hussain
Apr 2, 2009·Current Oncology Reports·Terence W Friedlander, Charles J Ryan
Jan 19, 2011·Current Oncology Reports·Mohamed Salem, Jorge A Garcia
Feb 27, 2013·Current Oncology Reports·Erin E EzzellBenjamin J George
Feb 12, 2013·Medical Oncology·Cátia MonteiroRui Medeiros
Feb 24, 2012·Journal of Biosciences·Simon MahoneyArun Dharmarajan
Jan 22, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·B MelladoP Gascón
Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J BellmuntJ Albanell
Oct 7, 2009·Genes & Nutrition·Marie-Hélène TeitenMarc Diederich
Jul 16, 2011·Hormones & Cancer·Sujit Basu, Donald J Tindall
Nov 30, 2011·Hormones & Cancer·Saroj NiraulaAnthony Michael Joshua
Jan 13, 2004·Biochemical and Biophysical Research Communications·Lin YangChawnshang Chang
May 26, 2005·Biochemical and Biophysical Research Communications·Leslie GapterKa-yun Ng
Jan 24, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hellmuth-Alexander MeyerBernard Haendler
Dec 12, 2003·European Urology·H G van der Poel
Jun 14, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Jean-Jacques KalachJean André
Apr 6, 2004·Molecular and Cellular Endocrinology·Feng Jiang, Zhou Wang
Nov 6, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Makoto SatoLily Wu
May 24, 2003·Biochemical and Biophysical Research Communications·Dev KaranSurinder K Batra
Oct 3, 2002·Cancer Letters·Jose D Debes, Donald J Tindall
Aug 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I RecchiaA Teti
Jan 1, 2003·Seminars in Cancer Biology·Sharon Amit, Yinon Ben-Neriah
Jul 10, 2003·The Lancet Oncology·David R Shaffer, Howard I Scher
Jun 10, 2008·Expert Reviews in Molecular Medicine·Imran AhmadHing Y Leung
Jul 10, 2013·Journal of Chemical Information and Modeling·Laura CaboniDavid G Lloyd
Sep 21, 2013·Journal of Medicinal Chemistry·Antonella PepeSanjay V Malhotra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved